Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about AGNPF

Recent news which mentions AGNPF

Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More
Tickers AGNPF ATAI CMND CMPS
Tags CMND Cannabis GHRS
From Benzinga
DMT For Stroke Treatment: Algernon Sets Phase 2 Clinical Trial Design
Tickers AGNPF
Tags Management DMT/Assisted Therapy AGNPF
From Benzinga
Psyched: Professional Practice Guidelines, DMT For Stroke, Dua Lipa &. Amanda Feilding, Clinical Results & More
Tickers AGNPF ATAI AWKNF CMPS
Tags Management Psychedelics Financing TRUFF
From Benzinga
DMT As A Treatment For Stroke? This Company Is Closer To Launching Its Phase 2 Study
Tickers AGNPF
Tags News Algernon NeuroScience AGNPF
From Benzinga
DMT's Clinical Path For Treating TBI And Stroke: Phase 1 Dosing Finished As Phase 2 Gears Up
Tickers AGNPF
Tags Management Benzinga Markets
From Benzinga
How To Finance A Psychedelics Business? Learn From These Four Companies
Tickers AGNPF CMND PSYGF
Tags Diamond Therapeutics Inc/ CMND Cannabis
From Benzinga
Intravenous DMT Therapy Seeks Ideal Dosage For Stroke And TBI Treatment
Tickers AGNPF
Tags Penny Stocks Cannabis Market News
From Benzinga
Psyched: 9 US Reform Bills, Ayahuasca 'A Release' For Prince Harry, At-Home Therapy & More
Tickers AGNPF AWKNF BRAXF CMPS
Tags PSIL Markets CMPS
From Benzinga
Algernon Pharmaceuticals AP-188 DMT Compound Shows Promise For The Treatment Of TBI
Tickers AGNPF
Tags AGNPF Penny Stocks Market News
From Benzinga
Algernon Pharmaceuticals Goes 4:1 In Forward Share Split After Announcing New TBI Program
Tickers AGNPF IPOS
Tags Penny Stocks Psychedelic/Assisted Therapies Forward Stock Split
From Benzinga
Psyched: Hawaii And Minnesota's Bills, Studying 2C-B Vs. Psilocybin, Filament CEO, Plus Brock Pierce And Jeremy Gardner Discuss The Industry's Future And More
Tickers AGNPF AWKNF CMND CYBN
Tags CYBN Market News Global
From Benzinga
Psyched: Four New States With Reform Bills, Psilocybin For Genetic Disorders And Functional Neurological Disorder, Struggle For Access & More
Tickers AGNPF AWKNF CYBN DMTTF
Tags DMTTF Markets PSIL
From Benzinga
Developing Psychedelic Treatments For Traumatic Brain Injury: Algernon Launches New Program
Tickers AGNPF TBI
Tags Cannabis General AGN Neuro
From Benzinga
Algernon Touts Positive Study Findings, Confirms Next Trial Phase With Escalated Dose
Tickers AGNPF
Tags News Guidance DMT Entities
From Benzinga
A Psychedelic Program For Treatment Of Stroke: New Clinical Trial Begins Dosing
Tickers AGNPF DMT
Tags Cannabis Market News Human Stroke
From Benzinga
Psychedelic Subsidiaries News: Blackhawk Spins Out Three Companies, Algernon Creates A New One
Tickers AGNPF
Tags Psychedelics Benzinga Markets
From Benzinga
EXCLUSIVE: Ayahuasca Pill Is Officially Here, Filament CEO Discusses Future Plans
Tickers AGNPF ATAI FLHLF
Tags Small Cap FLHLF Top Stories
From Benzinga
Psyched: Musk's Empathy Tweets, Psychedelics In Congress, Oregon's Opt-Outs, MAPS' MDMA Trial And More
Tickers AGNPF BMNDF CMND CMPS
Tags Cannabis REUN PSYK
From Benzinga
Psychedelic Therapeutics For Human Stroke: Participant Screening Expects To Begin Soon
Tickers AGNPF
Tags AGNPF Strokes News
From Benzinga
Tackling Depression With Psychedelics: New Phase 2 Clinical Study Begins At Yale University
Tickers AGNPF
Tags Penny Stocks Markets Yale University
From Benzinga
A Foundational Study On Stroke Is Ready. Here Is Why It's Important
Tickers AGNPF DMT
Tags Medical Research Ethics Committee Centre for Human Drug Research DMT
From Benzinga
Canadian Psychedelics Company To Begin First Global DMT Clinical Trial For Stroke Treatment
Tickers AGNPF
Tags Leiden University Medical Center Global Stroke
From Benzinga
Algernon Pharmaceuticals Closes Private Placement Round, Announces New Shareholder Distribution
Tickers AGNPF
Tags Cannabis Market News AGNPF
From Benzinga
Algernon Posts Mixed Bag Results From Mid Stage Chronic Cough Study
Tickers AGNPF
Tags Biotech News AGNPF
From Benzinga
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
Tickers AGNPF ALID ATAI AWKNF
Tags DELCF PSYCF MCURF
From Benzinga
There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are
Tickers AGNPF ALID ATAI AWKNF
Tags Market News NMLSF MYNDF
From Benzinga
Psyched: CaamTech Raises $22M, Mydecine To Launch Smoking Cessation Trial, Michigan Bill Could Decriminalize Psychedelics
Tickers AGNPF ALID ATAI FTRP
Tags ATAI psychedelics HAVLF
From Benzinga
Investors Should Avoid High-Risk Atossa Therapeutics
Tickers AGNPF ATOS GILD LLY
Tags NASDAQ:ATOS, NYSE:LLY,OTC:AGNPF,NASDAQ:SRNE,NASDAQ:GILD GILD LLY
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.